Stock EXAS EXACT SCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Exact Sciences Corporation

Equities

EXAS

US30063P1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
45.45 USD +0.44% Intraday chart for Exact Sciences Corporation -8.81% -38.56%
May. 24 Sector Update: Health Care Stocks Advance Pre-Bell Friday MT
May. 24 Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exact Sciences to Participate in June Investor Conferences
Sector Update: Health Care Stocks Advance Pre-Bell Friday
Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations At Asco®
U.S. FDA advisers back approval for Guardant's cancer test
Exact Sciences Earns 2024 Great Place to Work Certification
Exact Sciences Earns 2024 Great Place To Work® Certification™
Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
Exact Sciences : TCFD Report for the FY ended 12/29/2021
Foundation Fighting Blindness Partners with PreventionGenetics and InformedDNA to Advance My Retina Tracker Genetic Testing Program
Transcript : Exact Sciences Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM
Exact Sciences : Names Aaron Bloomer as New Chief Financial Officer
Exact Sciences Q1 Net Loss Widens, Revenue Increases; 2024 Revenue Outlook Maintained -- Shares Fall After Hours
Exact Sciences: Q1 Earnings Snapshot
Transcript : Exact Sciences Corporation, Q1 2024 Earnings Call, May 08, 2024
Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Revenue $637.5M, vs. Street Est of $626.8M
Exact Sciences Announces First-Quarter 2024 Results
Exact Sciences Corporation Reports Unaudited Consolidated Impairment of Long-Lived Assets for the First Quarter Ended March 31, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXAS Stock
  4. News Exact Sciences Corporation
  5. Other languages